Login to Your Account

Tengion Prices $30M IPO Despite Early Stage, High-Risk Programs

By Trista Morrison

Monday, April 12, 2010
Tengion Inc., which priced a $30 million initial public offering on Friday, was easily the earliest-stage biotech to try its luck in the current IPO window. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription